SiSaf Ltd Announces US$13.2 Million Series B Financing - Seite 2

About SiSaf

SiSaf are pioneers of silicon-based Bio-Courier technology that leverages the unique properties of elemental silicon (₁₄Si) to overcome the limitations of current drug technologies. Built upon a decade of research and patented technological innovation, SiSaf's platform is changing the way therapeutic molecules target disease helping to make tomorrow's precision medicines a reality. SiSaf is a commercial stage biopharmaceutical company headquartered in Guilford, UK, with fully integrated, state-of-the-art research labs, manufacturing, and bio-analytical facilities to fast track development. To learn more, please visit www.sisaf.com

About Bio-Courier Technology

SiSaf's first-to-market Bio-Courier platform technology leverages the unique properties of hybrid compositions of inorganic bioabsorbable silicon, with organic materials to address the significant challenges of stability, solubility, targeting and controlled release of complex therapeutic molecules.

The customizable design and fabrication provide unparalleled flexibility with respect to therapeutic molecule type and target cell location. Bio-Couriers degrade to the bioavailable form of silicon, eliminating the accumulation of potentially toxic or immune-activating material and supporting cell health. Cost-effective, scaled manufacturing provides unequalled capacity to address both rare diseases and large patient populations

About Vickers Venture Partners

Vickers Venture Partners is a global venture capital firm focused on early-stage investments in the technological and geographical mega trends of the world.  The firm's portfolio covers life sciences, technology, media, and telecommunications as well as consumer and financial services. The partners' track records include hits such as Baidu.com, Inc, Focus Media Holding Ltd, Kongzhong Corp, Cambridge Real Estate Investment Trust, Sunfun Info Co., Asian Food Channel (trade sale), UUCUN (trade sale), TWG Tea (trade sale), RTG Asia (trade sale), JJE (trade sale), Hillstone (trade sale, IPO), M-Daq (trade sale), Tenfen (trade sale), Kuyun (trade sale) and Mainspring (trade sale). The total market value of the companies that the partners have helped grow exceeds US$50 billion today. Vickers Venture Partners announced that they are targeting to raise US$500 million for their latest fund VI and have started investing from it after their first close in Oct 2019.